1McCloskey P, Tootle R, Selden C, et al. Modulation of hepatocyte function in an immortalized human hepatocyte cell line following exposure to liver-failure plasma. Artif Organs, 2002, 26: 340-348.
4Nozato E, Shiraishi M, Nishimaki T. Up-regulation of hepatocyte growth factor caused by an over-expression of transforming growth factor beta, in the rat model of fulminant hepatic failure. J Surg Res,2003, 115: 226-234.
5Pazzi P, Morsiani E, Vilei MT, et al. Serum bile acids in patients with liver failure supported with a bioartificial liver. Aliment Pharmacol Ther, 2002, 16: 1547-1554.
2Chang AJ, Dixit V, Saab S. Fulminant hepatic failure. Curr Treat Options Gastroenterol, 2003,6: 473-479.
3Kevin E J. Gunning Hepatic failure. Anaesthesia & intensive care medicine, 2006, 7: 119-120.
4Nils R, Fruhauf, Karl J. et al. A bioartificial liver support system using primary hepatocytes: a preclinical study in a new porcine hepatectomy model. Surgery, 2004, 136 : 47-56.
5Nieuwoudta M, Kunnikeb R, Smutsc M, et al. Standardization criteria for an isehemic surgical model of acute hepatic failure in pigs. Biomaterials, 2006,27 : 3836-3845.
6Hanid MA, Mackenzie RL, Jenner RE, et al. Intracranial pressure in pigs with surgically induced acute liver failure. Gastroenterology, 1979,76 : 123-131.
7Benoist S, Sarkis R, Baudrimont M, et al. A Reversible Model of Acute Hepatic Failure by Temporary Hepatic lschemia in the Pig. J Sur Res, 2000, 88 : 63- 69.
8Leist M, Gantner F, Kunstle G, et al. The 55 kD tumor necrosis factor receptor and CD95 independently signal murine hepatocyte apoptosis and subsequent liver failure. Mol Med, 1996,2:109-124.
9Eguia I., Materson BJ. Acetaminophen-related acute renal failure without fulminant liver failure. Pharmacotherapy, 1997, 17: 363- 370.
10Lubek BM, Basu PK, Wells PG. Metabolic evidence for the involvement of enzymatic bioactivation in the cataractogenicity of acetaminophen in genetically susceptible (C57BL/6) and resistant (DBA/2) murine strains. Toxicol Appl Pharmacol, 1988,94 :487- 495.
